Conversely, targeting the NLRP3 inflammasome pharmacologically may repress proliferation and metastasis of HCC, suggesting that this could be a therapeutic strategy and indicates that understanding the exact mechanisms of action of the inflammasome in HCC tumor proliferation, aggression and metastasis is required [98]. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.